Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.

about

Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.

P2860

Q38548881-77A4C676-E0BC-4205-B2D8-E4F8CE6C9F98 Q42109456-6C328C88-CAF2-4A83-A4CD-C4AFDD5E078A

P2860

Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.

Item

http://www.wikidata.org/entity/Q42430237

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@en

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@nl

type

Item

label

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@en

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@nl

prefLabel

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@en

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@nl

P1476

Fixed-ratio combination testin ...... ,467 Candida species isolates.

@en

P2093

Ronald N Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

Resistance to echinocandin-class antifungal drugs.

Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).

P304

4041-4043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00330-10

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael A Pfaller

Mariana Castanheira

P577

2010-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20547802

http://www.w3.org/2001/XMLSchema#string

P932

2935005

http://www.w3.org/2001/XMLSchema#string

Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.

about

P2860

P2860

Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932